Mode
Text Size
Log in / Sign up
N/A N=53 Randomized Treatment

Intervention for IPV Perinatal Women- RCT

Intimate Partner Violence

Enrolled (actual)
53
Serious AEs
28.3%
Results posted
Jan 2018
Primary outcome: Primary: Composite Abuse Scale (CAS)-CAS Victimization Total Score — 26.36; 16.56; 12.38; 16.52 units on a scale — p=0.4016

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
ROSE Program (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
Women and Infants Hospital of Rhode Island
Primary completion
Sep 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Composite Abuse Scale (CAS)-CAS Victimization Total Score
26.36; 16.56; 12.38; 16.52 0.4016
PRIMARY
Safety Behavior Checklist (SBC)
.28; .36; .28; .32 0.6011
PRIMARY
Effectiveness in Obtaining Resources Scale (EOR)
2.46; 3.48; 3.31; 3.43 0.8646
SECONDARY
Motivation Scale
6.18; 7.52; 6.81; 7.22 0.9085
SECONDARY
The Readiness to Change Contemplation Ladder
8.25; 8.08; 8.00; 7.26 0.4085

Summary

The study developed and assessed an innovative, high-reach, easily implementable, low-cost computer-delivered intervention (Reach out for a Safe Environment; ROSE Program) that addressed known barriers in early identification and intervention with perinatal women with IPV seeking treatment for mental illness.

Eligibility Criteria

Inclusion Criteria

  • Pregnant or postpartum women (up to 6 months after delivery)
  • Age 18 or older
  • Seeking mental health treatment at The Center for Women's Behavioral Health (WBH) at Women and Infants Hospital (WIH)
  • Endorsed any IPV during the past 12 months as measured by the Woman Abuse Screening Tool (WAST)

Exclusion Criteria

  • Inability to provide informed consent (e.g., due to psychosis, intoxication, or other clear cognitive impairment)
  • Inability to understand English (understand the consent form when read aloud and assessments that are narrated by computer)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02370394). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search